Berlin, Germany

Ekkehardt Schillinger

This inventor holds 1 USPTO granted patent. Top assignee: Schering Aktiengesellschaft. Active years: 1980.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ekkehardt Schillinger. Retrieved from https://idiyas.com/inventor/ekkehardt-schillinger

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 1980

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Ekkehardt Schillinger

Introduction

Ekkehardt Schillinger is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of prostaglandin derivatives. His work has led to advancements that are crucial for various medical applications.

Latest Patents

Schillinger holds a patent for Prostaglandin-I.sub.2 derivatives, specifically prostane derivatives of the formula ##STR1## wherein R.sub.1 is OR.sub.2 or NHR.sub.3. This innovation showcases his expertise in chemical compounds that have important therapeutic uses.

Career Highlights

Throughout his career, Schillinger has been associated with Schering Aktiengesellschaft, a prominent pharmaceutical company. His work there has allowed him to focus on innovative solutions in drug development and therapeutic applications.

Collaborations

He has collaborated with notable colleagues such as Werner Skuballa and Bernd Raduchel, contributing to a dynamic research environment that fosters innovation.

Conclusion

Ekkehardt Schillinger's contributions to the field of pharmaceuticals through his patent and collaborations highlight his role as an influential inventor. His work continues to impact the medical community positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…